Addex Therapeutics Ltd - Company Profile
Powered by
All the data and insights you need on Addex Therapeutics Ltd in one report.
- Save hours of research time and resources with
our up-to-date Addex Therapeutics Ltd Strategy Report
- Understand Addex Therapeutics Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Addex Therapeutics Ltd (Addex) is a biopharmaceutical company that focuses on the development of orally available, small molecule allosteric modulators for neurological disorders. The company’s strategic collaborations, focused R&D activities, and lead product: Dipraglurant extensive are its strengths. History of losses could be a cause for concern to the company. The company could benefit from orphan drug designation, changing demographics and strategic agreements. However, its performance could be affected by competitive environment, stringent regulations and cost containment pressures.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer